The evolution of lung cancer and impact of subclonal selection in TRACERx. (2023)

First Author: Frankell AM
Attributed to:  Enhancing immunogenicity in non-viral low mutation burden tumours funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41586-023-05783-5

PubMed Identifier: 37046096

Publication URI: http://europepmc.org/abstract/MED/37046096

Type: Journal Article/Review

Volume: 616

Parent Publication: Nature

Issue: 7957

ISSN: 0028-0836